Literature DB >> 3244552

Patent ductus arteriosus in a cohort of 1338 preterm infants: a collaborative study.

M van de Bor1, S P Verloove-Vanhorick, R Brand, J H Ruys.   

Abstract

As part of a prospective national survey on morbidity and mortality of all infants born at less than 32 weeks and/or weighing less than 1500 g in the Netherlands we studied the incidence of symptomatic patent ductus arteriosus (PDA) in infants surviving at least 24 hours. In 1252 of the 1338 infants the presence or absence of PDA could be established. The incidence of PDA was 10.7%. Logistic regression analyses revealed that idiopathic respiratory distress syndrome (IRDS) was the most predictive factor, followed in order of importance by septicaemia, birthweight, prolonged rupture of membranes and gestational age. None of the other maternal and perinatal factors showed any association with the occurrence of PDA. Furthermore, bronchopulmonary dysplasia (BPD) and necrotising enterocolitis (NEC) were found to be sequelae of PDA. The combination of IRDS, very pre-term birth and septicaemia should be considered as high risk for the development of PDA.

Entities:  

Mesh:

Year:  1988        PMID: 3244552     DOI: 10.1111/j.1365-3016.1988.tb00227.x

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  6 in total

1.  Towards rational management of the patent ductus arteriosus: the need for disease staging.

Authors:  Patrick J McNamara; Arvind Sehgal
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-11       Impact factor: 5.747

Review 2.  Exercise and the child born prematurely.

Authors:  H Hebestreit; O Bar-Or
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 3.  Inadvertent relaxation of the ductus arteriosus by pharmacologic agents that are commonly used in the neonatal period.

Authors:  Jeff Reese; Alex Veldman; Lisa Shah; Megan Vucovich; Robert B Cotton
Journal:  Semin Perinatol       Date:  2010-06       Impact factor: 3.300

4.  Aminoglycoside-mediated relaxation of the ductus arteriosus in sepsis-associated PDA.

Authors:  Megan M Vucovich; Robert B Cotton; Elaine L Shelton; Jeremy A Goettel; Noah J Ehinger; Stanley D Poole; Naoko Brown; James L Wynn; Bibhash C Paria; James C Slaughter; Reese H Clark; Mario A Rojas; Jeff Reese
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-03       Impact factor: 4.733

5.  Blood pressure changes during the first 24 hours of life and the association with the persistence of a patent ductus arteriosus and occurrence of intraventricular haemorrhage.

Authors:  Robert Boldt; Pauliina M Mäkelä; Lotta Immeli; Reijo Sund; Markus Leskinen; Päivi Luukkainen; Sture Andersson
Journal:  PLoS One       Date:  2021-11-30       Impact factor: 3.240

Review 6.  Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression.

Authors:  Moreyba Borges-Lujan; Gema E Gonzalez-Luis; Tom Roosen; Maurice J Huizing; Eduardo Villamor
Journal:  J Pers Med       Date:  2022-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.